Oasmia Pharmaceutical AB

At Oasmia Pharmaceutical AB we are developers of a new generation of drugs within the fields of human and veterinary oncology. We aim to develop and manufacture novel anti-cancer formulations based on well-established cytostatics which, in comparison with the current alternatives, demonstrate improved properties, a reduced side-effect profile and an expanded therapeutic area. Our suite of oncology products in development is based on our proprietary research within nanotechnologies and company patents.